• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR, Back to Search Results
Model Number OP-08W
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Anaphylactic Shock (1703)
Event Date 01/30/2024
Event Type  Injury  
Manufacturer Narrative
The complaint prodcut was not analyzed since it was discarded at the hospital.However, we investigated manufacturing and quality control records based on the lot number.According to the investigation, no potential for malfunction was found and no similar event has been reported with this lot number globally so far.Since anaphylactic shock occurred during treatment using the device, it was determined that a causal relationship "cannot be denied." the physician determined this event as "non-serious injury", but we determined this event as "serious injury".Anaphylactic shock is described as anaphylactoid reactions in ifu." e.Precautions 13.Monitor the patient constantly during treatment with the plasmaflo¿ op-05w(a).In the event of any of the following during treatment, immediately ensure the safety of the patient and take appropriate measures in accordance with the directions of the responsible physician.Presence of hemoglobin in separated plasma, due to hemolysis.The other potential reactions due to available substitute fluid such as fresh frozen plasma, plasma protein fraction are anaphylactoid reactions, hypocalcemia and infection." we will continue to monitor the occurrence of similar events carefully.
 
Event Description
This incident occurred when artificial liver treatment was performed on a patient in china.Plasmaflo op is identical model to op-05w(a) marketed in us.After starting treatment, the patient developed anaphylactic shock symptoms.Artificial liver treatment was stopped, and fluid replacement, vasopressors, and antiallergic drugs were administered to the patient, and the heart rate and blood pressure gradually returned to normal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR,
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
2111-2 oaza sato
oita-shi
oita, 87003 96
JA   8700396
Manufacturer Contact
naomi kagam
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0-006
JA   100-0006
MDR Report Key18957522
MDR Text Key338305317
Report Number8010002-2023-00050
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 02/27/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/22/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberOP-08W
Device Lot Number8N3V48
Was Device Available for Evaluation? No
Date Manufacturer Received02/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/08/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age66 YR
Patient SexMale
-
-